Holen Sie sich die Stockscreener-App
0.3652
10.33%
0.0342
Handel nachbörslich:
.34
-0.0252
-6.90%
Cellyan Biotechnology Co Ltd Aktie (HKPD) Neueste Nachrichten
Kam Leung Chan Net Worth (2026) - GuruFocus
Jingyan Wu Net Worth (2026) - GuruFocus
Shu Liu Net Worth (2026) - GuruFocus
Chenyu Andy Liang Net Worth (2026) - GuruFocus
Zifeng Wang Net Worth (2026) - GuruFocus
Mike Yao Zhou Net Worth (2026) - GuruFocus
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
Cellyan Biotechnology stock sinks 21% after hours: Here's what happened - MSN
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Cellyan Biotechnology Wins Second Nasdaq Grace Period to Fix Sub-$1 Share Price - TipRanks
Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened - Benzinga
Cellyan Biotechnology Gets 180-Day Nasdaq Grace Period on Bid-Price Rule - marketscreener.com
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance By Investing.com - Investing.com Nigeria
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
Thursday's after hours session: top gainers and losers - ChartMill
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period - The Manila Times
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance - Investing.com
Cellyan Biotechnology Receives Nasdaq Extension to Regain Minimum Bid Price Compliance - Quiver Quantitative
Nasdaq grants Cellyan Biotechnology (Nasdaq: HKPD) bid-price extension - Stock Titan
Cellyan Biotechnology Must Reach $1 Bid Price by Jan. 11 - Stock Titan
Cellyan Biotech (HKPD) Holds Steady Near Support After Minor DeclineMA Cross Alert - dars.gov.et
12 Industrials Stocks Moving In Wednesday's Intraday Session - Benzinga
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
[EFFECT] Cellyan Biotechnology Co., Ltd SEC Filing - Stock Titan
Cellyan Biotechnology (HKPD) Slides 3.78% to $0.40 as Biotech Volatility PersistsInsider Selling Alerts - dars.gov.et
Cellyan Biotech (HKPD) Slides 7.6%, Testing Key Support at $0.39Channel Projection - newsline.com
Cellyan Biotechnology (NASDAQ: HKPD) files $200M shelf to sell shares, debt - Stock Titan
Cellyan Biotechnology (HKPD) director CHAN Kam Leung files initial Form 3 - Stock Titan
12 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga
[Form 3] Cellyan Biotechnology Co., Ltd Initial Statement of Beneficial Ownership - Stock Titan
12 Industrials Stocks Moving In Tuesday's Intraday SessionBimergen Energy (AMEX:BESS), EHang Holdings - Benzinga
Cellyan Biotechnology (HKPD) Chief Strategy Officer listed with no Form 3 transactions - Stock Titan
Cellyan Biotechnology (HKPD) CFO Liu Shu files initial ownership Form 3 - Stock Titan
Cellyan Biotechnology (HKPD) director Zhou Mike Yao files initial Form 3 - Stock Titan
Cellyan Biotechnology (HKPD) director Wu Jingyan submits initial SEC Form 3 - Stock Titan
Cellyan Biotechnology (HKPD) CEO and director files Form 3 with no share transactions - Stock Titan
Cellyan Biotechnology (HKPD) Slumps 7.83%: Key Support at $0.50 Under PressureFibonacci Fan - The Legal Advocate
Cellyan Biotechnology (HKPD) Holds Steady Near Support After Marginal GainsAdvance Decline Volume - The Legal Advocate
HKPDCellyan Biotechnology Co Ltd Stock Price and Quote - Finviz
Cellyan Biotechnology (HKPD) Drops 3.6% as Shares Approach Critical $0.50 SupportButterfly Setup - The Legal Advocate
Cellyan Biotechnology Faces Resistance at $0.57 After Recent DeclineDark Pool Prints - dars.gov.et
12 Industrials Stocks Moving In Wednesday's Pre-Market SessionBrenmiller Energy (NASDAQ:BNRG), Smart P - Benzinga
Cellyan (HKPD) quarterly earnings report shows no revenue, EPS data available amid biotechnology sector headwinds.Shared Buy Zones - Newser
What net volume Cellyan (HKPD)? (Smart Money Outflows) 2026-04-29Buy Signals - newser.com
What leverage Cellyan (HKPD)? | HKPD Latest Quarter Earnings: Cellyan logs zero revenue, advances key drug pipeline progressSocial Trading Insights - newser.com
HKPD Latest Quarter Earnings: Cellyan logs zero revenue, advances key drug pipeline progressPretax Income Report - The Legal Advocate
HKPD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HKPD (Cellyan) posts 21.7 percent Q2 2025 revenue growth, shares drop 6.58 percent amid negative earnings.Dividend Increase Stocks - The Legal Advocate
Cellyan (HKPD) Stock: Is It Ready for Entry (Institutional Demand) 2026-04-18Index Investing - Cổng thông tin điện tử tỉnh Lào Cai
HKPD Technical Analysis & ETF Price Forecast - Intellectia AI
HKPD Stock Analysis: Cellyan Biotechnology Co. Ltd gains 1.59% to trade at 0.57 dollar - newsline.com
12 Industrials Stocks Moving In Monday's Intraday Session - Benzinga
According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), the selling shareholders of Cellyan Biotechnology Co Ltd may sell up to 12.5 million Class A ordinary shares from time to time in the future. - Bitget
12.5M shares for resale — Cellyan Biotechnology (NASDAQ: HKPD) - stocktitan.net
0.05%
0.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):